Continually moving forward
- Richard Park
Molecular diagnostics is becoming one of the dominant platforms of clinical laboratory medicine, representing one of the fastest growing segments in the IVD industry. It has emerged fully from research into clinical practice. According to Kalorama Information (New York), the molecular diagnostics market totaled $3.21 billion in revenues in 2007. The market is expected to reach $5.42 billion by 2012 with an estimated annual growth rate of 11%.
Special Report
DX Directions: Developing Companion Diagnostics for Personalized Medicine
This new special report examines the critical issues regarding personalized medicine and the development of companion diagnostics, which could significantly affect the IVD industry's future. More...
Webcasts
Register to access the archive of the most recent installment of IVD Technology’s Webcast series on the Fundamentals of In Vitro Diagnostics:
Developing Detection Technologies for Next-Generation Immunoassays
The performance characteristics of immunoassays are defined by how they are optimized to detect and display test results. Carefully selecting an appropriate detection method is critical to ensure the proper function of immunoassays, and the long-term manufacturability and performance of the final product. This FREE Webcast, "Developing Detection Technologies for Next-Generation Immunoassays," will examine current trends and future developments in detection technologies for immunoassays. Hosted by IVD Technology magazine, the Webcast will bring together a panel of experts from the IVD industry to review these issues and explain how common difficulties can be resolved.
Register to view any of the archived installments in IVD Technology’s Webcast series on the Fundamentals of In Vitro Diagnostics:
Blog: IVDT Insight
Written and produced by the editors of IVD Technology, IVDT Insight analyzes and provides links to the latest breaking headlines, offers informed commentary on the hottest industry topics, and provides a forum for our readers' opinions and feedback.
Recent Posts:
IVDT User Poll
Which types of molecular IVD tests is your company mostly interested in developing?
Current Editorial Focus
Molecular Diagnostics
Microfluidics for IVD analysis: triumphs and hurdles of centrifugal platforms
Part 1: Molecular fundamentals
Despite extensive research on microfluidic nucleic acid IVDs, there are few, if any, such systems on the market.
Molecular Diagnostics
Using DNA in multiplexed detection schemes
Various pursuits are ongoing to harness the advantages of DNA identification, yet there are many challenges still to be overcome to deliver such capabilities.
Assay Development
Automated quantitative microarray assay platforms
A microarray-based assay platform has been developed for high test throughput, with a fully automated protocol.
In Person
Trends and advances in molecular diagnostics
Alice Jacobs, MD, founder, chair, and CEO of IntelligentMDx
Taking a quality systems approach to assay development, addressing re-emerging infectious threats, and dealing with resistant pathogens are keeping those in the molecular diagnostics industry very busy.
